BAKER BROS. ADVISORS LP

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Value $
$9.36B
Signature - Title
Alexandra Toohey - Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by BAKER BROS. ADVISORS LP. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BAKER BROS. ADVISORS LP reported 95 stock holdings with total value $9.36B as of Q4 2024. Top holdings included INCY, ONC, ACAD, MDGL, and SMMT.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 95 $9.36B +$291M -$239M +$52M INCY, ONC, ACAD, MDGL, SMMT 13F-HR 2/14/2025, 04:12 PM
Q3 2024 93 $9.65B +$239M -$134M +$105M BGNE, INCY, ACAD, SMMT, MDGL 13F-HR 11/14/2024, 04:07 PM
Q2 2024 95 $7.83B +$925M -$626M +$300M INCY, BGNE, ACAD, MDGL, RVMD 13F-HR 8/14/2024, 04:05 PM
Q1 2024 85 $7.93B +$378M -$511M -$133M INCY, BGNE, ACAD, MDGL, RYTM 13F-HR 5/15/2024, 04:37 PM
Q4 2023 84 $8.79B +$625M -$10.3B -$9.68B INCY, BGNE, ACAD, MDGL, RYTM 13F-HR 2/14/2024, 05:12 PM
Q3 2023 114 $17.3B +$187M -$318M -$130M SGEN, BGNE, INCY, ACAD, BMRN 13F-HR 11/14/2023, 04:25 PM
Q2 2023 115 $17.3B +$437M -$522M -$85.6M SGEN, INCY, BGNE, ACAD, MDGL 13F-HR 8/14/2023, 05:13 PM
Q1 2023 105 $18.4B +$255M -$413M -$158M SGEN, INCY, BGNE, ACAD, MDGL 13F-HR 5/15/2023, 04:04 PM
Q4 2022 112 $16.7B +$272M -$93.9M +$178M SGEN, INCY, BGNE, BMRN, ACAD 13F-HR 2/14/2023, 03:06 PM
Q3 2022 112 $15.3B +$270M -$453M -$184M SGEN, INCY, BGNE, ACAD, BMRN 13F-HR 11/14/2022, 03:06 PM
Q2 2022 117 $17.6B +$252M -$94M +$158M SGEN, INCY, BGNE, BMRN, ACAD 13F-HR 8/15/2022, 04:56 PM
Q1 2022 117 $17.4B +$347M -$39.3M +$308M SGEN, INCY, BGNE, ACAD, BMRN 13F-HR 5/16/2022, 04:05 PM
Q4 2021 120 $20.6B +$386M -$152M +$234M SGEN, BGNE, INCY, KOD, ACAD 13F-HR 2/14/2022, 03:09 PM
Q3 2021 122 $22.8B +$600M -$307M +$293M SGEN, BGNE, INCY, KOD, ASND 13F-HR 11/15/2021, 03:58 PM
Q2 2021 120 $22.8B +$488M -$972M -$485M SGEN, BGNE, INCY, KOD, ACAD 13F-HR 8/16/2021, 04:11 PM
Q1 2021 126 $23.1B +$741M -$871M -$130M SGEN, BGNE, INCY, KOD, ACAD 13F-HR 5/17/2021, 04:03 PM
Q4 2020 125 $26.5B +$1.16B -$578M +$577M SGEN, BGNE, INCY, ACAD, KOD 13F-HR 2/16/2021, 02:59 PM
Q3 2020 118 $25B +$10.4B -$156M +$10.2B SGEN, BGNE, INCY, ACAD, ALXN 13F-HR 11/16/2020, 03:00 PM
Q2 2020 114 $22.7B +$622M -$658M -$36.1M SGENXXXX, INCY, BGNE, ACAD, ALXN 13F-HR 8/14/2020, 04:08 PM
Q1 2020 110 $16.2B +$318M -$78M +$240M SGENXXXX, INCY, ACAD, BGNE, ALXN 13F-HR 5/15/2020, 04:03 PM
Q4 2019 99 $18.8B +$689M -$335M +$354M SGENXXXX, INCY, BGNE, ACAD, ALXN 13F-HR 2/14/2020, 03:26 PM
Q3 2019 109 $14.7B +$343M -$114M +$229M SGENXXXX, INCY, ACAD, BGNE, ALXN 13F-HR 11/14/2019, 03:05 PM
Q2 2019 103 $14.7B +$308M -$543M -$235M SGENXXXX, INCY, BGNE, ALXN, ACAD 13F-HR 8/14/2019, 04:01 PM
Q1 2019 96 $15.6B +$258M -$218M +$40.6M SGENXXXX, INCY, BGNE, ALXN, ACAD 13F-HR 5/15/2019, 04:06 PM
Q4 2018 92 $12.2B +$526M -$251M +$274M SGENXXXX, INCY, BGNE, ALXN, GHDX 13F-HR 2/13/2019, 03:14 PM
Q3 2018 97 $15.1B +$407M -$422M -$15.3M SGENXXXX, INCY, BGNE, ALXN, GHDX 13F-HR 11/14/2018, 02:50 PM
Q2 2018 118 $13.3B +$1.49B -$101M +$1.39B SGENXXXX, INCY, BGNE, ALXN, BMRN 13F-HR 8/14/2018, 03:48 PM
Q1 2018 113 $11.8B +$818M -$196M +$622M INCY, SGENXXXX, BGNE, ALXN, BMRN 13F-HR 5/15/2018, 03:47 PM
Q4 2017 122 $11.5B +$716M -$257M +$459M INCY, SGENXXXX, ALXN, ACAD, BMRN 13F-HR 2/14/2018, 02:49 PM
Q3 2017 121 $12.3B +$271M -$86.5M +$185M INCY, SGENXXXX, ALXN, ACAD, BMRN 13F-HR 11/14/2017, 02:45 PM
Q2 2017 120 $11.4B +$420M -$49.1M +$370M INCY, SGENXXXX, ALXN, ACAD, BMRN 13F-HR 8/14/2017, 03:48 PM
Q1 2017 118 $12.2B +$1.55B -$39.8M +$1.51B INCY, SGENXXXX, ACAD, ALXN, GHDX 13F-HR 5/15/2017, 04:00 PM
Q4 2016 131 $10.2B +$302M -$908M -$606M SGENXXXX, INCY, ALXN, ACAD, GHDX 13F-HR 2/14/2017, 03:13 PM
Q3 2016 131 $11B +$258M -$66M +$192M SGENXXXX, INCY, ABBV, ACAD, ALXN 13F-HR 11/14/2016, 04:30 PM
Q2 2016 133 $9.53B +$82.1M -$71.5M +$10.6M INCY, SGENXXXX, ABBV, ACAD, ALXN 13F-HR 8/15/2016, 04:07 PM
Q1 2016 133 $9.48B +$970M -$28.3M +$942M INCY, SGENXXXX, ALXN, ABBV, ACAD 13F-HR 5/16/2016, 04:12 PM
Q4 2015 132 $12.1B +$479M -$60.7M +$419M INCY, SGENXXXX, ALXN, ABBV, ACAD 13F-HR 2/16/2016, 03:52 PM
Q3 2015 133 $10.8B +$1.45B -$37.6M +$1.41B INCY, SGENXXXX, ALXN, ABBV, ACAD 13F-HR 11/16/2015, 03:07 PM
Q2 2015 126 $11.4B +$2.52B -$106M +$2.41B INCY, SGENXXXX, ALXN, ABBV, ACAD 13F-HR 8/14/2015, 04:19 PM
Q1 2015 130 $12B +$633M -$121M +$512M PCYC, INCY, GEVA, SGENXXXX, ACAD 13F-HR 5/15/2015, 04:06 PM
Q4 2014 120 $9.79B +$882M -$117M +$765M PCYC, INCY, GEVA, SGENXXXX, AVNR 13F-HR 2/17/2015, 03:15 PM
Q3 2014 108 $7.94B +$381M -$25.9M +$355M PCYC, SGENXXXX, GEVA, INCY, ACAD 13F-HR 11/14/2014, 03:51 PM
Q2 2014 106 $8.15B +$433M -$97.1M +$336M GEVA, PCYC, SGENXXXX, INCY, ACAD 13F-HR 8/14/2014, 04:15 PM
Q1 2014 107 $7.87B +$656M -$153M +$503M SGENXXXX, GEVA, PCYC, INCY, ACAD 13F-HR 5/15/2014, 04:10 PM
Q4 2013 94 $7.09B PCYC, SGENXXXX, INCY, GEVA, ACAD 13F-HR 2/14/2014, 03:21 PM